These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 23954739)

  • 1. Clozapine pre-treatment has a protracted hypolocomotor effect on the induction and expression of amphetamine sensitization.
    Herrera AS; Casanova JP; Gatica RI; Escobar F; Fuentealba JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():1-6. PubMed ID: 23954739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine.
    Dietz DM; Tapocik J; Gaval-Cruz M; Kabbaj M
    Physiol Behav; 2005 Oct; 86(3):347-55. PubMed ID: 16126238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of locomotor sensitization by amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area.
    Vezina P; Queen AL
    Psychopharmacology (Berl); 2000 Aug; 151(2-3):184-91. PubMed ID: 10972464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necessary role for ventral tegmental area adenylate cyclase and protein kinase A in induction of behavioral sensitization to intraventral tegmental area amphetamine.
    Tolliver BK; Ho LB; Fox LM; Berger SP
    J Pharmacol Exp Ther; 1999 Apr; 289(1):38-47. PubMed ID: 10086985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased locomotor response to amphetamine induced by the repeated administration of the selective kappa-opioid receptor agonist U-69593.
    Fuentealba JA; Gysling K; Andrés ME
    Synapse; 2007 Sep; 61(9):771-7. PubMed ID: 17568430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventral Tegmental Area Dopamine Cell Activation during Male Rat Sexual Behavior Regulates Neuroplasticity and d-Amphetamine Cross-Sensitization following Sex Abstinence.
    Beloate LN; Omrani A; Adan RA; Webb IC; Coolen LM
    J Neurosci; 2016 Sep; 36(38):9949-61. PubMed ID: 27656032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat.
    Häggkvist J; Björkholm C; Steensland P; Lindholm S; Franck J; Schilström B
    Addict Biol; 2011 Jan; 16(1):20-9. PubMed ID: 20192948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated antipsychotic treatment progressively potentiates inhibition on phencyclidine-induced hyperlocomotion, but attenuates inhibition on amphetamine-induced hyperlocomotion: relevance to animal models of antipsychotic drugs.
    Sun T; Hu G; Li M
    Eur J Pharmacol; 2009 Jan; 602(2-3):334-42. PubMed ID: 19059234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentially altered mGluR1 and mGluR5 mRNA expression in rat caudate nucleus and nucleus accumbens in the development and expression of behavioral sensitization to repeated amphetamine administration.
    Mao L; Wang JQ
    Synapse; 2001 Sep; 41(3):230-40. PubMed ID: 11418936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in syntaxin-1B mRNA in the nucleus accumbens of amphetamine-sensitized rats.
    Bhardwaj SK; Cassidy CM; Srivastava LK
    Int J Neuropsychopharmacol; 2006 Dec; 9(6):751-9. PubMed ID: 16359582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphetamine locomotor sensitization is accompanied with an enhanced high K⁺-stimulated Dopamine release in the rat medial prefrontal cortex.
    Casanova JP; Velis GP; Fuentealba JA
    Behav Brain Res; 2013 Jan; 237():313-7. PubMed ID: 23047059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine and amphetamine produce cross-sensitization to nicotine-induced locomotor activity in mice.
    Celik E; Uzbay IT; Karakas S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):50-5. PubMed ID: 16084635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphetamine sensitization is accompanied by an increase in prelimbic cortex activity.
    Aguilar-Rivera MI; Casanova JP; Gatica RI; Quirk GJ; Fuentealba JA
    Neuroscience; 2015 Mar; 288():1-9. PubMed ID: 25542419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous neurotensin in the ventral tegmental area contributes to amphetamine behavioral sensitization.
    Panayi F; Colussi-Mas J; Lambás-Señas L; Renaud B; Scarna H; Bérod A
    Neuropsychopharmacology; 2005 May; 30(5):871-9. PubMed ID: 15637639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activation of dopamine release in the nucleus accumbens core and shell after acute or repeated amphetamine injections: a comparative study in the Roman high- and low-avoidance rat lines.
    Giorgi O; Piras G; Lecca D; Corda MG
    Neuroscience; 2005; 135(3):987-98. PubMed ID: 16154292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats.
    Meng ZH; Feldpaush DL; Merchant KM
    Brain Res Mol Brain Res; 1998 Oct; 61(1-2):39-50. PubMed ID: 9795122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-cycloserine inhibits the development and the expression of locomotor sensitization to amphetamine in rats.
    Gaiardi M; Colantoni A; De Luca V; Bartoletti M
    Behav Pharmacol; 2010 May; 21(3):165-70. PubMed ID: 20445441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking impact of clozapine on cocaine locomotor and sensitizing effects in rats.
    Filip M; Papla I; Nowak E; Przegaliński E
    Pol J Pharmacol; 2003; 55(6):1125-30. PubMed ID: 14730110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robust sensitization to amphetamine following intra-VTA cholera toxin administration.
    Byrnes JJ; Weinstein DM; Wallace LJ
    Synapse; 1997 Apr; 25(4):335-44. PubMed ID: 9097392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.